ScoreWhy is Xiangxue Pharmaceutical Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0.67%
- Poor long term growth as Net Sales has grown by an annual rate of -13.76% and Operating profit at -217.87% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With a fall in PBT of -38.06%, the company declared Very Negative results in Mar 25
- The company has declared negative results for the last 4 consecutive quarters
- NET SALES(HY) At CNY 734.11 MM has Grown at -34.77%
- NET PROFIT(HY) At CNY -730.3 MM has Grown at -158.25%
- OPERATING CASH FLOW(Y) Lowest at CNY -88.84 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -28.88%, its profits have fallen by -105.4%
4
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 15.18% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -28.88% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Xiangxue Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Xiangxue Pharmaceutical Co., Ltd.
-25.86%
2.88
70.59%
China Shanghai Composite
14.77%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-13.76%
EBIT Growth (5y)
-217.87%
EBIT to Interest (avg)
-0.99
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.24
Sales to Capital Employed (avg)
0.43
Tax Ratio
2.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.67%
ROE (avg)
0.51%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.73
EV to EBIT
-16.14
EV to EBITDA
-25.20
EV to Capital Employed
2.40
EV to Sales
7.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.88%
ROE (Latest)
-116.81%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 3.95%
PRE-TAX PROFIT(Q)
At CNY -79.54 MM has Grown at 62.18%
NET PROFIT(Q)
At CNY -88.77 MM has Grown at 58.67%
-29What is not working for the Company
NET SALES(HY)
At CNY 734.11 MM has Grown at -34.77%
NET PROFIT(HY)
At CNY -730.3 MM has Grown at -158.25%
OPERATING CASH FLOW(Y)
Lowest at CNY -88.84 MM
INTEREST(9M)
At CNY 177.41 MM has Grown at 7.11%
ROCE(HY)
Lowest at -63.77%
DEBT-EQUITY RATIO
(HY)
Highest at 226.79 %
RAW MATERIAL COST(Y)
Grown by 8.4% (YoY
CASH AND EQV(HY)
Lowest at CNY 202.26 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.77%
Here's what is working for Xiangxue Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY -79.54 MM has Grown at 62.18%
over average net sales of the previous four periods of CNY -210.34 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -88.77 MM has Grown at 58.67%
over average net sales of the previous four periods of CNY -214.8 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Inventory Turnover Ratio
Highest at 3.95%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Xiangxue Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at CNY -88.84 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at 226.79 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest
At CNY 177.41 MM has Grown at 7.11%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 417.91 MM has Fallen at -8.68%
over average net sales of the previous four periods of CNY 457.6 MMMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Cash and Eqv
Lowest at CNY 202.26 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 1.77%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 8.4% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
